Show results for
Refine by
Aneurysms Articles & Analysis
40 news found
Surgeons from Johns Hopkins conclude that “The exoscope offers a larger field of view, greater depth of field, greater illumination and magnification capabilities as compared to traditional optical microscopy” and that “the 3D exoscope system lends itself well to applications within spinal neurosurgery” (Khalifeh et al.). In the case of an aneurysm ...
Hykes served as the VP of Commercial Operations at Sequent Medical where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market. ...
“We are excited to expand our portfolio for treating brain aneurysms with the addition of the Numen™ Coil Embolization System,” comments James Romero, President, Americas of Rapid Medical. “The combination of our de Novo Comaneci™ device and the Numen™ coil expands physicians’ capabilities to treat complex aneurysms with ...
One in five patients experience a bleeding complication during large-bore endovascular procedures such as transcatheter aortic valve replacement (TAVR), endovascular aneurysm repair (EVAR) and percutaneous mechanical circulatory support. ...
Thoraflex Hybrid is a single use medical device combining a Gelweave polyester graft with a Nitinol self-expanding stent graft and is indicated for the open surgical repair or replacement of damaged or diseased vessels of the aortic arch and descending aorta with or without involvement of the ascending aorta in cases of aneurysm and/or dissection. Joseph Coselli, MD (Professor, ...
Balt, an innovative neurovascular company focused on developing, designing, and manufacturing solutions for treating complex, life-threatening conditions, including stroke, aneurysms, and arteriovenous malformations, today announced the appointment of Jeffrey Sachs as the Company's Chief Legal & Compliance Officer. ...
” Approximately one in every five patients will experience a bleeding complication during large-bore endovascular procedures such as transcatheter aortic valve replacement (TAVR), endovascular aneurysm repair (EVAR), and percutaneous MCS1. The average cost of a single bleeding complication incident across these large-bore procedures is approximately $18,000 with an ...
The partnership will enable Biomodex to speed the production of 3D-printed brain aneurysm models by reducing the time it takes to transform 2D medical images to 3D visuals. An estimated 6.5 million - or 1 in 50 - people in the United States have an unruptured brain aneurysm, according to the Brain Aneurysm Foundation. The Biomodex EVIAS™ ...
ByAxial3D
Balt, an innovative neurovascular company focused on developing, designing, and manufacturing solutions for treating complex, life-threatening conditions, including stroke, aneurysms, and arteriovenous malformations, today announced enrollment in the FIRST study has been completed. The FIRST study is an observational, prospective, multi-center, international, single-arm study ...
Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application to conduct a U.S. trial for the Contour Neurovascular System™, indicated for the treatment of intracranial aneurysms. The IDE approval follows the receipt of Breakthrough Device Designation from the FDA in February 2021. ...
Indicated for the treatment of intracranial aneurysms, the Contour Neurovascular System™, composed of fine mesh braid, represents a unique intrasaccular advancement in the market, as it targets the neck of the aneurysm, away from the vulnerable dome. ...
Endospan, a pioneer in off-the-shelf endovascular repair of aortic arch disease, announces the first implant of the NEXUS™ Aortic Arch Stent Graft System on a patient with a thoracic aortic aneurysm as part of the TRIOMPHE Study in Norfolk, Virginia, January 11, 2021. ...
Nitin Dange and was performed on a Middle Cerebral Aneurysm with a 7mm Contour device. Procedural time, including access and placement of the Contour, took a total of 28 minutes. ...
Francis Caputo, a specialist and expert in complex aortic aneurysmal disease. “This technology provides a promising future in endovascular aortic interventions. ...
” About Balt: Since it was established in 1977, Balt has worked with interventional physicians to develop devices to treat complex life-threatening neurovascular conditions such as ischemic strokes, aneurysms and arteriovenous malformations. A pioneer in the neurovascular field, Balt designs, manufactures and distributes the broadest portfolio of products in the ...
“We are very excited to have access to the ALTO device given its unique approach to excluding the aneurysm using a custom sealing technology, and the higher sealing ring enabled me to land and seal in healthy aortic tissue, which should give this patient a good long-term durable outcome,” Mr. ...
Bernard Timothy Baxter, MD, professor, department of surgery division of vascular surgery, University of Nebraska Medical Center, who is leading the NIH-NIA aneurysm study said, "There is a drastic need for this type of technology that can produce better indicators/blood tests and can tell us who has an undiagnosed aneurysm, and which aneurysms ...
“With both FDA approval and CE Mark, ALTO is an important therapy for physicians and their patients and yet another example of our highly differentiated portfolio of devices aimed at addressing the current unmet needs of endovascular aneurysm repair (EVAR). As we continue to execute our strategy, Endologix is committed to investing in the highest levels of clinical ...
Lastly, CE Mark of the ALTO system is yet another critical milestone for Endologix as we seek to introduce a portfolio of devices to address the current unmet needs of endovascular aneurysm repair (EVAR).” “ALTO offers a highly differentiated endovascular treatment option to AAA patients and includes design features that we believe will enhance ease-of-use, improve ...
About Cerus Endovascular Cerus Endovascular is a privately held, commercial-stage, medical device company engaged in the design and development of highly differentiated and proprietary interventional neuroradiology devices and delivery systems for the treatment of acute, life-threatening neurological conditions, specifically, intracranial aneurysms. The Company’s CE Marked ...